BMC and Compuware Partner to Help Customers Dramatically

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
BMC and Compuware Partner to Help Customers Dramatically Improve IBM(R) z Systems(R) Economics
  • Even as mainframe demand increases, spurred by mobile apps, Big Data, social and other drivers, IBM z Systems owners are being asked to slash their mainframe operating costs.
  • With MLC-based software costs often consuming 30 percent or more of mainframe budgets, organizations can achieve significant savings by 1) shifting where and when workloads run to minimize collective MSU peaks and 2) tuning applications to reduce their individual MSU utilization.
  • By partnering to deliver seamless integration of their respective offerings, BMC and Compuware are uniquely enabling customers to discover and exploit new opportunities for mainframe cost savings.

DETROIT and HOUSTON, Feb. 17, 2015 (GLOBE NEWSWIRE) -- Compuware Corporation and BMC Software, Inc. are partnering to dramatically improve the economics of IBM® z Systems ownership. By doing so, the two companies are empowering customers to significantly reduce mainframe opex—even as they more aggressively leverage their high-value mainframe applications, data and processing capacity to meet the challenges of the digital economy.

Mainframe workloads are growing significantly as web, mobile and Internet of Things (IoT) applications drive increasing transaction volumes. Capabilities offered on the newly-debuted IBM z13 are also likely to attract new workloads—including high-performance analytics, Java and Linux®.

This workload growth is precipitously driving up the Monthly License Charge (MLC) for IBM mainframe software, which for sub-capacity environments is generally impacted by the highest rolling four-hour average (R4HA) of mainframe utilization for all applications on each LPAR—measured in MSUs. Therefore IT can most effectively reduce its sizable IBM z Systems software costs by both 1) tuning each application to minimize its individual consumption of mainframe resources and 2) orchestrating application workloads to minimize the LPAR utilization peaks they generate collectively at any given time.

"The partnership between BMC and Compuware launches an integrated opportunity for mainframe customers to manage workload inefficiencies in a manner that has not been achievable to-date," said Frank DeSalvo, former research director at Gartner. "This innovation helps organizations leverage their IT budgets by enabling them to continuously optimize their mainframe workloads, resulting in cost effective decisions for both current and future spending."

BMC and Compuware are uniquely enabling customers to achieve these outcomes by integrating three complementary solutions:

  • BMC Cost Analyzer for zEnterprise is a financially intelligent workload management solution that enables customers to identify MLC cost drivers and take appropriate measures to reduce those costs—such as moving workloads to non-peak periods, running IBM subsystems on fewer LPARs, and capping LPAR utilization.
  • BMC MainView provides real-time identification of application performance issues, enabling customers to quickly eliminate wasteful MSU consumption.
  • Compuware Strobe delivers deep, granular and highly actionable insight into the behavior of application code in the IBM z Systems environment, allowing mainframe owners to quickly pinpoint inefficient sub-routines that can cause MSU consumption to be 20x or more greater than necessary.

One integration allows BMC Cost Analyzer to call Compuware Strobe for a detailed analysis of the specific application component for peak MLC periods, enabling customers to proactively tune applications that have the greatest impact on their monthly software licensing costs. A second integration with BMC MainView allows customers to either automatically or manually invoke Strobe performance analysis—empowering mainframe staffs to more quickly, efficiently and consistently perform cost-saving tuning tasks.

"BMC and Compuware have helped drive mainframe technology for decades, and today we are two of the most innovative companies delivering new solutions on the mainframe platform," said Bill Miller, president, ZSolutions and Select Technologies for BMC. "The integration of our key solutions helps mainframe customers achieve even greater cost efficiencies as they cope with the challenging combination of intensifying business demand and tight resource constraints."

"Customers are facing the loss of their most skilled and experienced mainframe staff at the same time as the opportunities and challenges of mainframe ownership are on the rise," said Compuware CEO Chris O'Malley. "BMC and Compuware are responding to this urgent market need by innovating and collaborating in a way that is unprecedented among mainframe ISVs—and that directly addresses the twin issues of improving the mainframe's performance economics and simplifying mainframe operations for a new generation of IT professionals."

The integrations are the first of several the two companies plan as part of a broader partnership that also includes use of each other's technology within their own organizations. BMC and Compuware's products and planned integrations will be demonstrated at SHARE in Seattle, Wash. March 2-4.

About BMC

BMC delivers software solutions that help IT transform digital enterprises for the ultimate competitive business advantage. We have worked with thousands of leading companies to create and deliver powerful IT management services. From mainframe to cloud to mobile, we pair high-speed digital innovation with robust IT industrialization—allowing our customers to provide amazing user experiences with optimized IT performance, cost, compliance, and productivity. We believe that technology is the heart of every business, and that IT drives business to the digital age. To learn more, visit bmc.com .

About Compuware Corporation

Compuware empowers the world's largest companies to excel in the digital economy by fully leveraging their high-value mainframe intellectual property. We do this by delivering highly innovative mainframe application development and performance optimization solutions that uniquely enable IT to drive business value. Learn more at www.compuware.com .

Follow us on:

BMC, BMC Software, the BMC logo and the BMC Software logo and all other BMC Software product and service names are owned by BMC Software Inc. and are registered or pending registration in the U.S. Patent and Trademark Office or in the trademark offices of other countries.

Compuware, the Compuware logo and all other Compuware Software product and service names are owned by Compuware Corporation and are registered or pending registration in the U.S. Patent and Trademark Office or in the trademark offices of other countries.

IBM®, z Systems®, and z13™ are trademarks or registered trademarks of International Business Machines Corporation in the United States, other countries, or both.

Java is a registered trademark of Oracle and/or its affiliates. Other names may be trademarks of their respective owners.

Linux is the registered trademark of Linus Torvalds.

Press Contact Kristina LeBlanc, The Medialink Group (508) 930-5636 Tami Casey, Senior PR Manager, BMC Software (408) 571-7131 Mary McCarthy, Public Relations Manager, Compuware (313) 227-8188 For Sales and Marketing Information BMC Software, Inc. 2101 CityWest Boulevard Houston, TX 77042 855-834-7487 http://www.bmc.com/mainframe Compuware Corporation One Campus Martius Detroit, MI 48226 800-521-9353 http://www.compuware.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading